Literature DB >> 782542

Specific inhibition of the termination process of protein synthesis by negamycin.

Y Uehara, M Hori, H Umezawa.   

Abstract

The effect of negamycin and its derivatives on protein synthesis in an Escherichia coli cell-free system was determined. (1) Unlike tetracycline and streptomycin, negamycin did not inhibit codon-specific binding of aminoacyl-tRNA to ribosomes. (2) The miscoding activity of the genamycin family compounds was not parallel with the activity inhibiting the termination reaction. (3) Although negamycin strongly inhibited the overall termination reaction, it inhibited only slightly the two substeps involved; the formation of releasing factor 1 - U-A-[3H]G - ribosome complex and the peptidyl-transferase action (release of formylmethionine from the initiation complex by puromycin). (4) The termination reaction performed with ribosomes from either streptomycin- or kanamycin-resistant E. coli cells was sensitive to negamycin. These results indicate that the inhbitory effect of negamycin on the termination reaction is specific to negamycin and distinct from that of tetracycline and streptomycin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782542     DOI: 10.1016/0005-2787(76)90495-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.

Authors:  Nelson B Olivier; Roger B Altman; Jonas Noeske; Gregory S Basarab; Erin Code; Andrew D Ferguson; Ning Gao; Jian Huang; Manuel F Juette; Stephania Livchak; Matthew D Miller; D Bryan Prince; Jamie H D Cate; Ed T Buurman; Scott C Blanchard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Negamycin binds to the wall of the nascent chain exit tunnel of the 50S ribosomal subunit.

Authors:  Susan J Schroeder; Gregor Blaha; Peter B Moore
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

3.  Ribosomal function and its inhibition by antibiotics in prokaryotes.

Authors:  K H Nierhaus; H G Wittmann
Journal:  Naturwissenschaften       Date:  1980-05

Review 4.  Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases.

Authors:  Kim M Keeling; David M Bedwell
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-07-06       Impact factor: 9.957

5.  Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.

Authors:  David C McKinney; Gregory S Basarab; Alexis I Cocozaki; Melinda A Foulk; Matthew D Miller; Anatoly M Ruvinsky; Clay W Scott; Kumar Thakur; Liang Zhao; Ed T Buurman; Sridhar Narayan
Journal:  ACS Med Chem Lett       Date:  2015-07-12       Impact factor: 4.345

6.  Two regions of the Escherichia coli 16S ribosomal RNA are important for decoding stop signals in polypeptide chain termination.

Authors:  C M Brown; K K McCaughan; W P Tate
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

Review 7.  Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.

Authors:  Jinzhong Lin; Dejian Zhou; Thomas A Steitz; Yury S Polikanov; Matthieu G Gagnon
Journal:  Annu Rev Biochem       Date:  2018-03-23       Impact factor: 27.258

8.  An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome.

Authors:  Tanja Florin; Cristina Maracci; Michael Graf; Prajwal Karki; Dorota Klepacki; Otto Berninghausen; Roland Beckmann; Nora Vázquez-Laslop; Daniel N Wilson; Marina V Rodnina; Alexander S Mankin
Journal:  Nat Struct Mol Biol       Date:  2017-07-24       Impact factor: 15.369

9.  CTELS: A Cell-Free System for the Analysis of Translation Termination Rate.

Authors:  Kseniya A Lashkevich; Valeriya I Shlyk; Artem S Kushchenko; Vadim N Gladyshev; Elena Z Alkalaeva; Sergey E Dmitriev
Journal:  Biomolecules       Date:  2020-06-16

10.  Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.

Authors:  Yury S Polikanov; Teresa Szal; Fuyan Jiang; Pulkit Gupta; Ryoichi Matsuda; Masataka Shiozuka; Thomas A Steitz; Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Mol Cell       Date:  2014-10-09       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.